MeSH tree: D03.132.436
In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated ...
Sep 3, 2026
0
159
In recent years, psychedelic drugs have attracted growing interest as potential treatments for conditions including depression, anxiety and addiction. Although these drugs are often considered one group, researchers from ...
Sep 3, 2026
0
21
Over the past few decades, some psychiatrists and medical researchers have been running controlled clinical trials to assess the potential therapeutic value of psychedelics, substances that alter perception, mood and thinking ...
A landmark five-year study by Monash University has found psychedelics reorganize brain patterns, giving clinicians powerful new insights into their therapeutic potential.
Aug 19, 2026
0
81
The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is ...
Aug 6, 2026
0
10
A small pilot study from the Center for Psychedelic Research at Imperial College London indicates that psilocybin—the active ingredient in psychedelic "magic mushrooms"—may have potential as a treatment for anorexia nervosa ...
Jul 9, 2026
0
7
In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD. The internet is full of personal accounts describing improved concentration, ...
Jul 1, 2026
0
20
The therapeutic use of psychedelic drugs has attracted no shortage of media and scientific interest in recent years—and this is only likely to grow.
Jun 25, 2026
0
3
Some psychedelics, psychoactive substances that alter people's mood, perceptions and mental processes, were recently found to be promising alternative treatments for some mental health disorders. The substance that has attracted ...
Monash University researchers have launched Australia's first clinical trial to test whether the psychedelic drug psilocybin is an effective treatment for persistent post-concussion symptoms.
Jun 15, 2026
0
14
